Elevance Health (NYSE: ELV) 报告季度每股收益为 $3.84，高于分析师共识预期的 $3.81，超出0.79%。与去年同期的 $5.62 相比减少了31.67%。公司报告季度销售额为 $449.9亿，高于分析师共识预期的 $448.6亿，超出0.28%。与去年同期的 $424.5亿 相比增长了5.97%。

以上内容来自Benzinga Earnings专栏，原文如下：

Elevance Health (NYSE:ELV) reported quarterly earnings of $3.84 per share which beat the analyst consensus estimate of $3.81 by 0.79 percent. This is a 31.67 percent decrease over earnings of $5.62 per share from the same period last year. The company reported quarterly sales of $44.99 billion which beat the analyst consensus estimate of $44.86 billion by 0.28 percent. This is a 5.97 percent increase over sales of $42.45 billion the same period last year.